Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

S M Swain

Showing results (51-60 of 76) with videos related to

Pageof 8
Sort By:
Annals of Oncology : Official Journal of the European Society for Medical Oncology|April 2, 2014
Incidence of central nervous system metastases in patients with HER2-positive metastatic breast cancer treated with pertuzumab, trastuzumab, and docetaxel: results from the randomized phase III study CLEOPATRAS M Swain, J Baselga, D Miles, et al.
Cancer Research|August 1, 1989
Heterogeneous expression of erbB-2 messenger RNA in human breast cancerC R King, S M Swain, L Porter, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|July 1, 1989
Fluorouracil and high-dose leucovorin in previously treated patients with metastatic breast cancerS M Swain, M E Lippman, E F Egan, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|April 1, 1997
Delayed administration of dexrazoxane provides cardioprotection for patients with advanced breast cancer treated with doxorubicin-containing therapyS M Swain, F S Whaley, M C Gerber, et al.
Investigational New Drugs|March 7, 2012
Phase I trial of dasatinib and ixabepilone in patients with solid tumorsP Herbolsheimer, R Kapoor, K L Smith, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|November 8, 2017
Effect of docetaxel duration on clinical outcomes: exploratory analysis of CLEOPATRA, a phase III randomized controlled trialD Miles, Y-H Im, A Fung, et al.
The American Surgeon|January 1, 1990
Effect of preoperative chemotherapy on mastectomy for locally advanced breast cancerD N Danforth, M E Lippman, H McDonald, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|July 23, 2013
Health-related quality-of-life assessment in CLEOPATRA, a phase III study combining pertuzumab with trastuzumab and docetaxel in metastatic breast cancerJ Cortés, J Baselga, Y-H Im, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|May 21, 2005
Neoadjuvant docetaxel followed by adjuvant doxorubicin and cyclophosphamide in patients with stage III breast cancerW J Gradishar, S B Wedam, M Jahanzeb, et al.
Pharmacogenetics|December 1, 1993
Relationship of CYP2D6 (debrisoquine hydroxylase) genotype to breast cancer susceptibilityE T Buchert, R L Woosley, S M Swain, et al.
Pageof 8

Showing results (51-60 of 76) with videos related to

Sort By:
Pageof 8
Annals of Oncology : Official Journal of the European Society for Medical Oncology|April 2, 2014
Incidence of central nervous system metastases in patients with HER2-positive metastatic breast cancer treated with pertuzumab, trastuzumab, and docetaxel: results from the randomized phase III study CLEOPATRAS M Swain, J Baselga, D Miles, et al.
Cancer Research|August 1, 1989
Heterogeneous expression of erbB-2 messenger RNA in human breast cancerC R King, S M Swain, L Porter, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|July 1, 1989
Fluorouracil and high-dose leucovorin in previously treated patients with metastatic breast cancerS M Swain, M E Lippman, E F Egan, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|April 1, 1997
Delayed administration of dexrazoxane provides cardioprotection for patients with advanced breast cancer treated with doxorubicin-containing therapyS M Swain, F S Whaley, M C Gerber, et al.
Investigational New Drugs|March 7, 2012
Phase I trial of dasatinib and ixabepilone in patients with solid tumorsP Herbolsheimer, R Kapoor, K L Smith, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|November 8, 2017
Effect of docetaxel duration on clinical outcomes: exploratory analysis of CLEOPATRA, a phase III randomized controlled trialD Miles, Y-H Im, A Fung, et al.
The American Surgeon|January 1, 1990
Effect of preoperative chemotherapy on mastectomy for locally advanced breast cancerD N Danforth, M E Lippman, H McDonald, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|July 23, 2013
Health-related quality-of-life assessment in CLEOPATRA, a phase III study combining pertuzumab with trastuzumab and docetaxel in metastatic breast cancerJ Cortés, J Baselga, Y-H Im, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|May 21, 2005
Neoadjuvant docetaxel followed by adjuvant doxorubicin and cyclophosphamide in patients with stage III breast cancerW J Gradishar, S B Wedam, M Jahanzeb, et al.
Pharmacogenetics|December 1, 1993
Relationship of CYP2D6 (debrisoquine hydroxylase) genotype to breast cancer susceptibilityE T Buchert, R L Woosley, S M Swain, et al.
Pageof 8